Sosei Heptares’ $2.6 Billion Collaboration With Neurocrine Biosciences Inc

Giulia Di Palma Europe Legal Chronicle
Tagged:

Gowling WLG’s advised Sosei Heptares on the deal.Sosei Heptares on its collaboration with San Diego based Neurocrine Biosciences Inc to develop novel muscarinic receptor agonist compounds,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Giulia Di Palma

Author: Giulia Di Palma

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here